Abraxas Petroleum Corporation (NASDAQ: AXAS), an independent natural gas and crude oil exploitation and production company, is focused on increasing shareholder value while maintaining financial flexibility and liquidity. The company is currently committed to developing its existing asset base while acquiring leases that fit strategically within its current portfolio. Abraxas targets conventional reservoirs, as well as emerging resource plays. For further information, visit the Company’s web site at www.abraxaspetroleum.com.
Kodiak Oil & Gas Corp. (AMEX: KOG), an independent energy exploration and development company, is focused on exploring, developing and producing oil and natural gas in the U.S. Rocky Mountains. The company’s primary operating areas are the Green River Basin in Wyoming and the Williston Basin in North Dakota and Montana. Kodiak’s geologists, petroleum engineers and geophysicists have years of relevant industry experience in these basins. For further information, visit the Company’s web site at www.kodiakog.com.
Kodiak Exploration Limited (TSX: KXL CN) is a Canadian mineral exploration company. The Vent Gold Zone is known as one of the company’s most important targets because of the large extent of sulphide mineralization and intense alteration that measures approximately 3.0 kilometres long and between 400 and 700 metres wide. The Hercules Gold Property, another significant target, has great access and infrastructure, and gold-bearing veins are concentrated along at least two large gold-bearing structures. For further information, visit the Company’s web site at www.kodiakexp.com.
Kodiak Energy, Inc. (TSX: KDK CN), a publicly traded junior oil and gas exploration and development company, is a multi-project company with a significant land position of more than 340,000 gross acres leased for exploration and development in multiple jurisdictions and work environments. The company’s focus is on the development of onshore oil, gas and CO2 properties within North America. In an effort to minimize shareholder dilution, financing activities are project based, within stages of each project. For further information, visit the Company’s web site at www.kodiakpetroleum.com.
Kit digital (OTC BB: KITD) is a pioneer provider in video distributions in online, mobile and set-top box environments. With video as the company’s passion, Kit digital recently announced it was selected by TV2Moro, a new firm backed by several top-tier ethnic television aggregators and producers, to deploy a new IPTV set-top box (STB) service to deliver programming to ethnic consumers in North America. With this new deal in place and the growth of the young company, Kit digital may optimize the future of the marketplace. For further information, visit the company website at: www.kit-digital.com.
Kinbauri Gold Corp. (TSX: KNB CN) is a junior mining company based in Ottawa, Ontario, Canada with an immediate focus to upgrade resources to reserves and complete a mine development plan at El Valle. Through their efforts, they anticipate the production of gold and copper at the mine and mill complex by 2010. This site has the potential to become the largest gold producer in Western Europe. Other mining properties include: Corcoesto, and five North American precious metals properties. For further information, visit the Company’s web site at www.kinbauri-gold.com.
KBL Healthcare Acquisition Corporation III (AMEX: KHA) is a special purpose acquisition company (SPAC) established for the purpose of effecting a merger, capital stock exchange, stock purchase, asset acquisition or other similar business combination with an operating business in the healthcare or healthcare-related industries. In an IPO dated July 31, 2007, KBL raised over $138 million. With headquarters located in New York, the young company is quickly becoming a force in the healthcare field. For further information, visit the company website at: www.kblhealthcare.com.
Jingwei International Ltd. (OTC BB: JNGW) is an integrated marketing service provider that has quickly become one of the leaders in providing direct marketing services to global companies doing business in China. The company has a geographic presence in 20 cities and a customer database that contains detailed biographical, demographic and purchasing data of over 300 million Chinese consumers. Jingwei enables companies to reach their targeted advertising audience. For further information, visit the company website at: www.jingweicom.com.
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), a specialty pharmaceutical company, focuses their efforts on identifying, developing and commercializing innovative products designed to address unmet medical needs in neurology and psychiatry. Their goal as a company is to develop a broad portfolio of products through internal development and acquisition/in-licensing while utilizing a specialty sales force to promote products in target markets. For further information, visit the Company’s web site at www.jazzpharmaceuticals.com.
Javelin Pharmaceuticals, Inc. (AMEX: JAV), a specialty pharmaceutical company, is focused on applying its novel proprietary technologies to develop new drugs and improve existing drugs that target unmet as well as underserved medical needs in the pain management market. Compared to existing treatments, Javelin’s product candidates, which include Dyloject™, Rylomine™ and PMI-150, provide better pain relief with fewer adverse side effects. For further information, visit the Company’s web site at www.javelinpharma.com.
Jaguar Mining Inc. (TSX: JAG CN), one of the fastest growing gold producers in the world, intends to substantially expand gold production from 70,000 ounces produced in 2007 to approximately 700,000 ounces by 2014 through its wholly-owned operations in the state of Minas Gerais, Brazil. The company is currently in active exploration and development of additional mineral resources at its 72,000 acre land base in Minas Gerais and on an additional concession base totaling 159,000 acres in the state of Ceará. For further information, visit the Company’s web site at www.jaguarmining.com.
Ivernia Inc. (TSX: IVW CN), an international base metals, exploration, development and operating company, is the sole owner and operator of the Magellan lead mine in Western Australia. Once the mine reaches full production, it is anticipated to be one of the top five lead-producing mines in the world. Currently, the mine is under temporary care and maintenance pending final requisite shipping approvals from the Western Australian Government to employ a newly-developed sealed shipping process to transfer its lead concentrate to port for export. For further information, visit the Company’s web site at www.ivernia.com.
Iteris, Inc. (AMEX: ITI), a leader in the traffic management market, is focused on the development and application of advanced technologies that reduce traffic congestion, minimize the environmental impact of traffic congestion and improve the safety of surface transportation systems. By integrating outdoor image processing, traffic engineering and information technology, the company provides a wide array of Intelligent Transportation Systems and driver safety solutions to customers worldwide. For further information, visit the Company’s web site at www.iteris.com.
INX Inc. (NASDAQ: INXI) is a publicly traded network infrastructure professional services firm delivering best-of-class “Business Ready Solutions” to enterprise organizations. The company designs, implements, and supports the IP network infrastructure with a special emphasis on the Call Flow, Messaging, and Enablement layers. Inx Inc. is led by James H. Long who serves as the company’s CEO and Chairman of the Board. Long has a strong reputation in his field and an aggressive style that allows Inx to stay a step ahead of the competition. For further information, visit the company website at: www.inxi.com.
International Royalty Corporation (AMEX: ROY), a global mineral royalty company, has more than 85 royalties including an effective 2.7% NSR on the Voisey’s Bay mine, a sliding scale NSR on the Chilean portion of the Pascua-Lama project, and a 1.5% NSR on approximately 3.0 million acres of gold lands in Western Australia. The company is led by CEO Douglas Silver who has 25 years of experience as an active professional in the minerals industries. For further information, visit the Company’s web site at www.internationalroyalty.com.
International Montoro Resources Inc. (TSX: IMT CN), an emerging resource company, is focused on the acquisition, exploration and development of Uranium mineral properties in Saskatchewan, Ontario, British Columbia and Labrador as well as other resource properties in New Brunswick and Ontario. The company has been listed on the TSX Venture Exchange (formerly Vancouver Stock Exchange) for 18 years and has submitted its application to list on the Frankfurt Stock Exchange. For further information, visit the Company’s web site at www.montororesources.com.
Inter-Atlantic Financial, Inc. (AMEX: IAN) is a newly organized blank check company formed for the purpose of acquiring, through a merger, a capital stock exchange, asset acquisition, stock purchase or other similar business combination, an unidentified domestic and/or foreign operating business in the financial services industry or businesses deriving a majority of their revenues from providing services to financial services companies, including for example, payment processing companies and technology providers. For further information, visit the company website at: www.interatlantic.com.
InterAmerican Acquisition Group Inc. (OTC BB: IAQG) is a blank check company recently formed for the purpose of acquiring, through a merger, stock exchange, asset acquisition or other similar business combination, an unidentified operating business. The company specializes in Project Management, Project Financing and Investment Banking. Recently, the company made news by raising $46 million. For further information, visit the company website at: www.interamerican-group.com.
Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company’s web site at www.insmed.com.
InSite Vision Incorporated (AMEX: ISV) is focused on developing novel ophthalmic products for the treatment of a growing range of common eye problems, including ocular infection, glaucoma, and retinal disease. Their goal as a company is to provide patients and physicians with better treatment options that help preserve and improve vision worldwide. By leveraging their proprietary DuraSite® drug delivery technology, the company is creating alternative ocular anti-infective therapies that may provide substantial advantages over existing treatment options. For further information, visit the Company’s web site at www.insite.com.
Inovio Biomedical Corporation (AMEX: INO)Inovio Biomedical Corporation (AMEX: INO) has their focus on developing multiple DNA-based immunotherapies. The company is known as a leading developer of human applications of electroporation using brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceutical. Inovio’s DNA delivery technology has demonstrated the ability to substantially increase gene expression and immune responses from DNA vaccines. For further information, visit the Company’s web site at www.inovio.com.
Inhibitex, Inc. (NASDAQ: INHX) is a biopharmaceutical company engaging in the development of differentiated anti-infective products designed to prevent and treat serious infections. The company’s products include FV-100, a nucleoside analogue prodrug; HIV Integrase Inhibitors class of anti-retroviral agents; and a series of nucleoside and non-nucleoside HCV polymerase inhibitors designed to treat the hepatitis C virus. For further information, visit the Company’s web site at www.inhibitex.com.
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), an innovative cancer drug discovery and development company, is focused on discovering, developing, and delivering best-in-class medicines designed to treat cancer and related conditions. The company leverages its proven scientific expertise and passion for developing novel small molecule drugs designed to target emerging cancer pathways. Infinity’s two most advanced programs are examples of its innovative approach to oncology drug discovery and development. For further information, visit the Company’s web site at www.infi.com.
India Globalization Capital, Inc. (AMEX: IGC) is a company that was formed to acquire operating businesses located in India through merger, capital stock exchange, asset acquisition or other similar business combination. India Globalization Capital (IGC) has three main competencies which are: Highway and Heavy Construction, Mining and Quarrying, and Civil Construction and Engineering of high-temperature plants. IGC is a step ahead of their competition because they are the only Indian infrastructure company listed and trading in the United States. For further information, visit the company
Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV), a specialty pharmaceutical company, is focused on the acquisition, development, and commercialization of products designed to treat conditions in urology and endocrinology. The company’s approved products include SANCTURA® and SANCTURA XR(TM) for overactive bladder, SUPPRELIN® LA for central precocious puberty, VANTAS® for advanced prostate cancer, and DELATESTRYL® to treat male hypogonadism. For further information, visit the Company’s web site at www.indevus.com.